跳至主要内容
临床试验/NCT03039738
NCT03039738终止不适用

A Prospective Evaluation of Surveillance Monitoring as an Alternative to Telemetry in Patients Scheduled for Telemetry Without American Heart Association (AHA) Indication

Medtronic - MITG2 个研究点 分布在 1 个国家目标入组 206 人开始时间: 2017年4月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
206
试验地点
2
主要终点
Hospital Length of Stay (LOS) as Assessed by Review of Medical Records

研究概览

简要总结

The purpose of the study is to evaluate the impact of surveillance monitoring versus telemetry monitoring on clinical, healthcare economics, resource utilization, and qualitative outcomes.

详细描述

This will be single-center, prospective, pilot, pre/post implementation study to collect post-market data on hospitalized subjects monitored via telemetry and surveillance monitoring

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed and dated informed consent by subject
  • Male or female 18 years of age or older
  • Expected hospitalized admission on the general care floor or medical surgical unit for at least one overnight stay and/or > 12 hours
  • Scheduled for telemetry monitoring
  • Diagnosis indicates American Heart Association (AHA) telemetry Class III or none and therefore not indicated for telemetry monitoring
  • For surveillance monitoring group subjects, treating provider who scheduled subject for telemetry agrees to alternative monitoring plan of surveillance monitoring
  • Willingness to have study devices attached and hair shaved at sensor location as needed during study participation
  • Willingness to participate in all aspects of the study

排除标准

  • Implanted pacemaker or atrial defibrillator
  • Allergy or sensitivity to ECG leads or adhesives that are similar to ECG leads
  • Current AHA Class I or II indication/prescription for telemetry monitoring
  • Prescription for other continuous condition monitoring such as capnography or pulse oximetry
  • Ongoing opioid therapy by patient-controlled analgesia (PCA), by epidural or intrathecal infusions or by intravenous analgesia, per Investigator discretion
  • Ventilated or intubated patients at the time of enrollment
  • Female subject is pregnant, lactating, trying to get pregnant, or has a positive pregnancy test for women with childbearing potential
  • Condition that, in the opinion of the investigator, may prevent completion of the study or protocol requirements
  • Subject is considered as being morbidly obese (defined as BMI >50.0)

研究组 & 干预措施

Telemetry Monitoring Arm

Active Comparator

The telemetry group will serve as the control group and will be monitored via the site's standard of care telemetry protocols.

干预措施: Telemetry Monitoring (Device)

Surveillance Monitoring Arm

Experimental

Subjects in the surveillance monitoring group will alternatively be admitted to medical surgical unit and be monitored via the surveillance monitoring platform.

干预措施: Vital Sync IM & VPMP (Surveillance Monitoring) (Device)

结局指标

主要结局

Hospital Length of Stay (LOS) as Assessed by Review of Medical Records

时间窗: Baseline to end of hospital stay (or up to 30 day post enrollment)

LOS will be determined by comparing LOS Between the Surveillance Monitoring and Telemetry Monitoring Period Arms.

次要结局

  • Associated Health Care Costs (HCC) as Determined by Review of Billing Records(Baseline to end of hospital stay (or up to 30 days post enrollment))
  • Number of Participants With Hospital Unit Transfers (HUT) as Determined by Review of Medical Records(Baseline to end of hospital stay (or up to 30 days post enrollment))
  • Length of Stay (LOS) in the ICU as Determined by Review of Medical Records(Baseline to end of hospital stay (or up to 30 days post enrollment))
  • Number of Participants With Clinical Interventions (CI) as Determined by Review of Medical Records(Baseline to end of hospital stay (or up to 30 days post enrollment))
  • Time of Rapid Response Team Activation to Time of a Threshold Notification as Measured by the Surveillance Monitoring System Only(Baseline to end of hospital stay (or up to 30 days post enrollment))
  • Clinical Team and Patient Satisfaction as Measured by Qualitative Questionnaires(Baseline to end of hospital stay (or up to 30 days post enrollment))
  • Clinicians Familiarity With AHA Guidelines and Telemetry Utilization as Measured by Qualitative Questionnaires(Baseline to end of hospital stay (or up to 30 days post enrollment))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验